Metabolic correction of dyslipidemia in patients with nonalcoholic fatty liver disease as a new therapy policy

To study the impact of infusion therapy with the metabolic modulator remaxol on lipid metabolic parameters and target organ (liver, kidney) function in metabolic syndrome (MS). The investigation enrolled 90 patients (54 men and 36 women) with primary nonalcoholic steatohepatitis that was associated...

Full description

Saved in:

Bibliographic Details
Published in:	Terapevtic̆eskii arhiv Vol. 85; no. 4; pp. 71 - 76
Main Authors:	Stel'makh, V V, Kozlov, V K
Format:	Journal Article
Language:	Russian
Published:	Russia (Federation) "Consilium Medicum" Publishing house 01.01.2013
Subjects:	Adult Aged diabetic nephropathy dyslipidemia Dyslipidemias - drug therapy Dyslipidemias - metabolism Fatty Liver - drug therapy Fatty Liver - metabolism Female Humans Male metabolic syndrome Metabolic Syndrome - drug therapy Metabolic Syndrome - metabolism Middle Aged Non-alcoholic Fatty Liver Disease nonalcoholic steatohepatitis pathogenetic therapy remaxol S-Adenosylmethionine - administration & dosage S-Adenosylmethionine - pharmacology Succinates - administration & dosage Succinates - pharmacology succinic acid Treatment Outcome Young Adult
ISSN:	0040-3660, 2309-5342
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!